NINGBO INNO PHARMCHEM CO.,LTD. is committed to supplying critical pharmaceutical intermediates that drive progress in global health initiatives. Dolutegravir Sodium, identified by its CAS number 1051375-19-9, is a key product in our portfolio, essential for the synthesis of advanced anti-HIV medications.

As a potent pharmaceutical intermediate, Dolutegravir Sodium powder is integral to the formulation of integrase strand transfer inhibitors, a class of drugs that has transformed the landscape of HIV treatment. These inhibitors play a vital role in preventing the virus from replicating by interfering with its ability to integrate into the host's DNA. The high purity of our Dolutegravir Sodium, often exceeding 99% as a white powder, ensures that the final drug products are both effective and safe for patients.

The development of drugs that employ Dolutegravir Sodium as a core component offers significant advantages, including high potency, a robust resistance profile, and convenience in dosing. This has led to a paradigm shift in HIV management, allowing individuals to lead healthier, more productive lives. Pharmaceutical companies rely on the consistent quality and availability of this intermediate to meet the growing global demand for these treatments.

NINGBO INNO PHARMCHEM CO.,LTD. understands the critical nature of its role in the pharmaceutical supply chain. By providing high-quality Dolutegravir Sodium, we support the continuous innovation and production efforts aimed at combating HIV. Our dedication to excellence ensures that researchers and manufacturers have access to the reliable materials needed to push the boundaries of antiviral therapy.

For those in the pharmaceutical industry seeking a dependable source for Dolutegravir Sodium powder, NINGBO INNO PHARMCHEM CO.,LTD. offers superior products and services. Our contribution to the availability of this crucial intermediate directly supports the ongoing global effort to combat HIV.